Creo Medical has reported its headline FY25 results, delivering fully on its guided revenue and cost savings targets for the year. Core revenues were reported at £6.0m, 50% y-o-y growth and within the 40–60% growth guidance. Notably, the sales uptick was driven by both an increase in new users and
